<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR21">
 <label>21.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Iyengar</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Kavanagh</surname>
    <given-names>BD</given-names>
   </name>
   <name>
    <surname>Wardak</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Smith</surname>
    <given-names>I</given-names>
   </name>
   <name>
    <surname>Ahn</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Gerber</surname>
    <given-names>DE</given-names>
   </name>
   <name>
    <surname>Dowell</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Hughes</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Abdulrahman</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Camidge</surname>
    <given-names>DR</given-names>
   </name>
   <name>
    <surname>Gaspar</surname>
    <given-names>LE</given-names>
   </name>
   <name>
    <surname>Doebele</surname>
    <given-names>RC</given-names>
   </name>
   <name>
    <surname>Bunn</surname>
    <given-names>PA</given-names>
   </name>
   <name>
    <surname>Choy</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Timmerman</surname>
    <given-names>R</given-names>
   </name>
  </person-group>
  <article-title>Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer</article-title>
  <source>J Clin Oncol</source>
  <year>2014</year>
  <volume>32</volume>
  <issue>34</issue>
  <fpage>3824</fpage>
  <lpage>3830</lpage>
  <pub-id pub-id-type="doi">10.1200/JCO.2014.56.7412</pub-id>
  <?supplied-pmid 25349291?>
  <pub-id pub-id-type="pmid">25349291</pub-id>
 </element-citation>
</ref>
